Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice

Harshini Neelakantan, Ronald J. Tallarida, Zachary W. Reichenbach, Ronald F. Tuma, Sara J. Ward, Ellen A. Walker

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Cannabinoid and opioid agonists can display overlapping behavioral effects and the combination of these agonists is known to produce enhanced antinociception in several rodent models of acute and chronic pain. The present study investigated the antinociceptive effects of the nonpsychoactive cannabinoid, cannabidiol (CBD) and the μ-opioid agonist morphine, both alone and in combination, using three behavioral models in mice, to test the hypothesis that combinations of morphine and CBD would produce synergistic effects. The effects of morphine, CBD, and morphine/CBD combinations were assessed in the following assays: (a) acetic acid-stimulated stretching; (b) acetic acid-decreased operant responding for palatable food; and (c) hot plate thermal nociception. Morphine alone produced antinociceptive effects in all three models of acute nociception, whereas CBD alone produced antinociception only in the acetic acid-stimulated stretching assay. The nature of the interactions between morphine and CBD combinations were assessed quantitatively based on the principle of dose equivalence. Combinations of CBD and morphine produced synergistic effects in reversing acetic acid-stimulated stretching behavior, but subadditive effects in the hot plate thermal nociceptive assay and the acetic acid-decreased operant responding for palatable food assay. These results suggest that distinct mechanisms of action underlie the interactions between CBD and morphine in the three different behavioral assays and that the choice of appropriate combination therapies for the treatment of acute pain conditions may depend on the underlying pain type and stimulus modality.

Original languageEnglish (US)
Pages (from-to)304-314
Number of pages11
JournalBehavioural Pharmacology
Volume26
Issue number3
DOIs
StatePublished - Apr 1 2015
Externally publishedYes

Fingerprint

Cannabidiol
Morphine
Acetic Acid
Nociception
Acute Pain
Opioid Analgesics
Hot Temperature
Cannabinoid Receptor Agonists
Food
Cannabinoids
Chronic Pain
Rodentia
Pain

Keywords

  • acetic acid
  • acute nociception
  • cannabidiol
  • dose equivalence
  • drug combination
  • hot plate
  • morphine
  • mouse
  • operant responding

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health
  • Medicine(all)

Cite this

Neelakantan, H., Tallarida, R. J., Reichenbach, Z. W., Tuma, R. F., Ward, S. J., & Walker, E. A. (2015). Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice. Behavioural Pharmacology, 26(3), 304-314. https://doi.org/10.1097/FBP.0000000000000119

Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice. / Neelakantan, Harshini; Tallarida, Ronald J.; Reichenbach, Zachary W.; Tuma, Ronald F.; Ward, Sara J.; Walker, Ellen A.

In: Behavioural Pharmacology, Vol. 26, No. 3, 01.04.2015, p. 304-314.

Research output: Contribution to journalArticle

Neelakantan, H, Tallarida, RJ, Reichenbach, ZW, Tuma, RF, Ward, SJ & Walker, EA 2015, 'Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice', Behavioural Pharmacology, vol. 26, no. 3, pp. 304-314. https://doi.org/10.1097/FBP.0000000000000119
Neelakantan, Harshini ; Tallarida, Ronald J. ; Reichenbach, Zachary W. ; Tuma, Ronald F. ; Ward, Sara J. ; Walker, Ellen A. / Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice. In: Behavioural Pharmacology. 2015 ; Vol. 26, No. 3. pp. 304-314.
@article{cd3b5f1d4bc04b9abfa616257cf0ff1d,
title = "Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice",
abstract = "Cannabinoid and opioid agonists can display overlapping behavioral effects and the combination of these agonists is known to produce enhanced antinociception in several rodent models of acute and chronic pain. The present study investigated the antinociceptive effects of the nonpsychoactive cannabinoid, cannabidiol (CBD) and the μ-opioid agonist morphine, both alone and in combination, using three behavioral models in mice, to test the hypothesis that combinations of morphine and CBD would produce synergistic effects. The effects of morphine, CBD, and morphine/CBD combinations were assessed in the following assays: (a) acetic acid-stimulated stretching; (b) acetic acid-decreased operant responding for palatable food; and (c) hot plate thermal nociception. Morphine alone produced antinociceptive effects in all three models of acute nociception, whereas CBD alone produced antinociception only in the acetic acid-stimulated stretching assay. The nature of the interactions between morphine and CBD combinations were assessed quantitatively based on the principle of dose equivalence. Combinations of CBD and morphine produced synergistic effects in reversing acetic acid-stimulated stretching behavior, but subadditive effects in the hot plate thermal nociceptive assay and the acetic acid-decreased operant responding for palatable food assay. These results suggest that distinct mechanisms of action underlie the interactions between CBD and morphine in the three different behavioral assays and that the choice of appropriate combination therapies for the treatment of acute pain conditions may depend on the underlying pain type and stimulus modality.",
keywords = "acetic acid, acute nociception, cannabidiol, dose equivalence, drug combination, hot plate, morphine, mouse, operant responding",
author = "Harshini Neelakantan and Tallarida, {Ronald J.} and Reichenbach, {Zachary W.} and Tuma, {Ronald F.} and Ward, {Sara J.} and Walker, {Ellen A.}",
year = "2015",
month = "4",
day = "1",
doi = "10.1097/FBP.0000000000000119",
language = "English (US)",
volume = "26",
pages = "304--314",
journal = "Behavioural Pharmacology",
issn = "0955-8810",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice

AU - Neelakantan, Harshini

AU - Tallarida, Ronald J.

AU - Reichenbach, Zachary W.

AU - Tuma, Ronald F.

AU - Ward, Sara J.

AU - Walker, Ellen A.

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Cannabinoid and opioid agonists can display overlapping behavioral effects and the combination of these agonists is known to produce enhanced antinociception in several rodent models of acute and chronic pain. The present study investigated the antinociceptive effects of the nonpsychoactive cannabinoid, cannabidiol (CBD) and the μ-opioid agonist morphine, both alone and in combination, using three behavioral models in mice, to test the hypothesis that combinations of morphine and CBD would produce synergistic effects. The effects of morphine, CBD, and morphine/CBD combinations were assessed in the following assays: (a) acetic acid-stimulated stretching; (b) acetic acid-decreased operant responding for palatable food; and (c) hot plate thermal nociception. Morphine alone produced antinociceptive effects in all three models of acute nociception, whereas CBD alone produced antinociception only in the acetic acid-stimulated stretching assay. The nature of the interactions between morphine and CBD combinations were assessed quantitatively based on the principle of dose equivalence. Combinations of CBD and morphine produced synergistic effects in reversing acetic acid-stimulated stretching behavior, but subadditive effects in the hot plate thermal nociceptive assay and the acetic acid-decreased operant responding for palatable food assay. These results suggest that distinct mechanisms of action underlie the interactions between CBD and morphine in the three different behavioral assays and that the choice of appropriate combination therapies for the treatment of acute pain conditions may depend on the underlying pain type and stimulus modality.

AB - Cannabinoid and opioid agonists can display overlapping behavioral effects and the combination of these agonists is known to produce enhanced antinociception in several rodent models of acute and chronic pain. The present study investigated the antinociceptive effects of the nonpsychoactive cannabinoid, cannabidiol (CBD) and the μ-opioid agonist morphine, both alone and in combination, using three behavioral models in mice, to test the hypothesis that combinations of morphine and CBD would produce synergistic effects. The effects of morphine, CBD, and morphine/CBD combinations were assessed in the following assays: (a) acetic acid-stimulated stretching; (b) acetic acid-decreased operant responding for palatable food; and (c) hot plate thermal nociception. Morphine alone produced antinociceptive effects in all three models of acute nociception, whereas CBD alone produced antinociception only in the acetic acid-stimulated stretching assay. The nature of the interactions between morphine and CBD combinations were assessed quantitatively based on the principle of dose equivalence. Combinations of CBD and morphine produced synergistic effects in reversing acetic acid-stimulated stretching behavior, but subadditive effects in the hot plate thermal nociceptive assay and the acetic acid-decreased operant responding for palatable food assay. These results suggest that distinct mechanisms of action underlie the interactions between CBD and morphine in the three different behavioral assays and that the choice of appropriate combination therapies for the treatment of acute pain conditions may depend on the underlying pain type and stimulus modality.

KW - acetic acid

KW - acute nociception

KW - cannabidiol

KW - dose equivalence

KW - drug combination

KW - hot plate

KW - morphine

KW - mouse

KW - operant responding

UR - http://www.scopus.com/inward/record.url?scp=84938597060&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938597060&partnerID=8YFLogxK

U2 - 10.1097/FBP.0000000000000119

DO - 10.1097/FBP.0000000000000119

M3 - Article

VL - 26

SP - 304

EP - 314

JO - Behavioural Pharmacology

JF - Behavioural Pharmacology

SN - 0955-8810

IS - 3

ER -